Automakers and suppliers are unlikely to find immediate alternatives to a shortage of resin used to make brake- and fuel-system components because of their pre-production vetting processes, according to IHS Automotive.
“Given the component testing and approval processes employed by” automakers and suppliers, “it is unlikely to be the work of a moment to find or develop a substitutable alternative material,” the Englewood, Colorado-based researcher said today in a post on its website.
More than 200 executives from companies including General Motors Co., Volkswagen AG, Toyota Motor Corp. and Ford Motor Co. met yesterday at a summit near Detroit to find other options for resin after a March 31 explosion at chemical maker Evonik Industries AG. The blast at Evonik’s Marl, Germany, factory that made Cyclododecatriene, also called CDT, halved the global source of the resin called PA-12.
Officials formed six technical committees aimed at mitigating the effect that the PA-12 shortage may have on production of parts and finished vehicles, Randi Berris, a spokeswoman for the Automotive Industry Action Group, wrote today in an e-mail. The group is hosting “multiple technical follow-up meetings” during the next few weeks on the issue, she said.
“It is understood that the mood at the AIGP meeting on Tuesday was extremely serious and there was significant concern over the potential for production disruptions in the component industry, with obvious knock-on effects” for automakers, IHS Automotive said in its report, which doesn’t list an author.